1Y Return
3Y Return
5Y Return
10Y Return
Stock SIP Return Calculator
Over the past
1 year
3 years
Total Investment of ₹65,00,000
Would have become ₹NaN (NaN%)
Stock Performance
52 Week Low - High
Today’s Low - High
Open
Prev. Close
Total Traded Value
Fundamental
Market Cap (in crs)
Face Value
Turnover (in lacs)
Key Metrics
Qtr Change %
New 52W Low in past week
-8.7
TTM PE Ratio
Below industry Median
35.7
Price to Book Ratio
Low in industry
1.3
Dividend yield 1yr %
High in industry
1.5
TTM PEG Ratio
PEG TTM is much higher than 1
10.1
Sandu Pharmaceuticals Ltd Key Financials
*All values are in ₹ Cr.
*All values are in ₹ Cr.
*All values are in ₹ Cr.
*All values are in ₹ Cr.
Sandu Pharmaceuticals Ltd Quarterly Revenue
| Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|
17.7 Cr | 17.05 Cr | 15.6 Cr | 17.43 Cr | 16.61 Cr |
Sandu Pharmaceuticals Ltd Yearly Revenue
| Mar 2024 | Mar 2023 |
|---|---|
67.7 Cr | 65.68 Cr |
Sandu Pharmaceuticals Ltd Quarterly Net Profit/Loss
| Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|
0.5 Cr | 0.17 Cr | 0.59 Cr | 0.21 Cr | 0.55 Cr |
Sandu Pharmaceuticals Ltd Yearly Net Profit/Loss
| Mar 2024 | Mar 2023 |
|---|---|
1.46 Cr | 1.52 Cr |
Sandu Pharmaceuticals Ltd Technical Analysis
Moving Averages Analysis
Moving Averages Analysis
Current Price
5Day EMA
54.00
10Day EMA
54.70
12Day EMA
54.90
20Day EMA
55.50
26Day EMA
55.80
50Day EMA
56.60
100Day EMA
57.80
200Day EMA
59.50
5Day SMA
54.10
10Day SMA
55.10
20Day SMA
55.70
30Day SMA
56.30
50Day SMA
56.70
100Day SMA
58.50
150Day SMA
59.00
200Day SMA
59.50
Delivery & Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume |
|---|---|---|
Day Rs | 850 Rs | 1652 Rs |
Week Rs | 1578 Rs | 1954 Rs |
Month Rs | 3084 Rs | 4784 Rs |
Resistance & Support
53.69
Pivot
Resistance
First Resistance
54.78
Second Resistance
56.08
Third Resistance
57.17
Support
First Support
52.39
Second support
51.30
Third Support
50
Relative Strength Index
38.68
Money Flow Index
78.47
MACD
-0.83
MACD Signal
-0.54
Average True Range
2.05
Average Directional Index
20.90
Rate of Change (21)
-3.76
Rate of Change (125)
-11.04
Similar stocks
Similar Stocks
Peer comparison
Compare
| Company | Market Price | Market Cap | 52W Low | 52W High |
|---|---|---|---|---|
Gujarat Terce Laboratories Ltd. | - | - | - | |
Sandu Pharmaceuticals Ltd. | - | - | - | |
Roopa Industries Ltd. | - | - | - | |
ANG Lifesciences India Ltd. | - | - | - | |
Chandra Bhagat Pharma Ltd. | - | - | - | |
50.87 | 46.98 | 80 | ||
Walpar Nutritions Ltd. | - | - | - |
Sandu Pharmaceuticals Ltd Company background
Founded in: 1985
Managing director: Umesh B Sandu
Sandu Pharmaceuticals Ltd (SPL) was established in 1985. The Company is mainly engaged in the business of manufacturing and trading of Ayurvedic medicines under the brand name SANDU.SPL came out with a public issue of 17.70 lac equity shares at par, aggregating Rs 1.77 cr, in Sep.94, to partfinance its new project in Goa costing Rs 7.28 cr to manufacture ayurvedic medicines and formulations. This plant employs the latest material handling systems and other modern machinery and has the most hygienic production facilities to attain the highest possible quality standards. Ayurvedic products have a very good market in India and abroad due to their minimal side effects.The company commenced commercial production of Ayurvedic Medicines Formulations, at the Goa plant in 199697. Thereafter, it commenced production of manufacturing Unit II in Goa from May, 2002.
Sandu Pharmaceuticals Ltd FAQs
How can I buy Sandu Pharmaceuticals Ltd shares?
You can easily buy Sandu Pharmaceuticals Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
Open Demat Account
